Thursday, May 28, 2026
ADVT 
International

US issues record-high 1.4 mn visas to Indians in 2023

Darpan News Desk IANS, 29 Jan, 2024 01:57 PM
  • US issues record-high 1.4 mn visas to Indians in 2023

New Delhi, Jan 29 (IANS) Bringing down the visitor visa appointment wait times by 75 per cent, the US Consular Team in India processed a record-smashing 1.4 million US visas in the year 2023.

Stating that the demand across all visa classes was unprecedented -- with a 60 per cent increase in applications compared to 2022 -- the US Embassy and Consulates said on Monday that Indians now represent one out of every 10 US visa applicants around the world.

In addition, visitor visas (B1/B2) rebounded to represent the second-highest number of applications in the US Mission’s history -- over 700,000.

The US Embassy and Consulates said that it met this demand through a three-month staffing surge in Mumbai early in the year, by increased permanent staff levels, and through the employment of innovative technical solutions.

"Process improvements and investments in staffing have brought the appointment wait time for visitor visas down from an average of 1,000 days to only 250 days around the country. Wait times are minimal in all other categories," the statement read.

Last year, the US consular team in India issued over 140,000 student visas -- more than in any other country in the world setting a record for the third year in a row.

As of now, Mumbai, New Delhi, Hyderabad, and Chennai stand as the top four student visa processing posts in the world.

With these surging numbers, Indian students have become the largest group of international graduate students in the United States and make up more than a quarter of the over one million foreign students studying in the country.

Stating that employment visas remain a top priority, the Embassy stated that in 2024, a pilot program will allow eligible H-1B holders to renew their visas in the United States, further streamlining the process for this group.

Further, Consular Team India consolidated most petition-based visa processing in Chennai and Hyderabad to increase efficiency.

This led to the processing of over 380,000 employment visas for Indians and their family members in 2023 and allowed the US Mission to maintain a minimal appointment wait time.

The Consulate General Mumbai eliminated a queue of over 31,000 immigrant visa cases delayed by the Covid-19 pandemic.

"Those who have a pending immigrant visa petition and are ready for scheduling can now obtain an appointment within the standard, pre-pandemic appointment window," the Embassy stated.

MORE International ARTICLES

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK

UN: Europe's pandemic restrictions are absolutely necessary

UN: Europe's pandemic restrictions are absolutely necessary
In a meda briefing on Thursday, Dr. Hans Kluge warned that even more drastic steps might be needed in such “unprecedented times.”

UN: Europe's pandemic restrictions are absolutely necessary